Uncategorized

New Releases from NCBI BookshelfComparing Two Ways to Help Sexual and Gender Minority Men Who Have Been Sexually Abused Reduce Depression and Increase Mental Health Treatment Engagement [Internet].Comparing Two Ways to Help Sexual and Gender Minority Men Who Have Been Sexually Abused Reduce Depression and Increase Mental Health Treatment Engagement [Internet].

Sexual abuse of boys and men is a public health problem that has received little attention from clinical scholars and […]

Uncategorized

New Releases from NCBI BookshelfUsing Graphic Novels when Choosing Treatment for Alcohol Use Disorder [Internet].Using Graphic Novels when Choosing Treatment for Alcohol Use Disorder [Internet].

Leave a Comment / Uncategorized / admin

Many patients with alcohol use disorder (AUD) are not provided evidence-based counseling and medication-assisted treatment (MAT) as part of their

Uncategorized

New Releases from NCBI BookshelfDeveloping and Testing a New Method for Comparing More Than Two Treatments Using Electronic Health Records [Internet].Developing and Testing a New Method for Comparing More Than Two Treatments Using Electronic Health Records [Internet].

Leave a Comment / Uncategorized / admin

In circumstances where randomized controlled trials are not practical or ethical, large-scale data collected from “real-world” clinical settings are fertile

Uncategorized

New Releases from NCBI BookshelfLutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours.Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours.

Leave a Comment / Uncategorized / admin

Post Content

Uncategorized

New Releases from NCBI BookshelfMirikizumab (Omvoh): Indication: For the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, loss of response, or were intolerant to either conventional therapy or a biologic treatment: Reimbursement Recommendation [Internet].Mirikizumab (Omvoh): Indication: For the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, loss of response, or were intolerant to either conventional therapy or a biologic treatment: Reimbursement Recommendation [Internet].

Leave a Comment / Uncategorized / admin

Canada’s Drug Agency (CDA-AMC) recommends that Omvoh be reimbursed by public drug plans for the treatment of moderately to severely

Uncategorized

New Releases from NCBI BookshelfIsatuximab (Sarclisa): Therapeutic area: Multiple myeloma: Reimbursement Review [Internet].Isatuximab (Sarclisa): Therapeutic area: Multiple myeloma: Reimbursement Review [Internet].

Leave a Comment / Uncategorized / admin

Post Content

Uncategorized

New Releases from NCBI BookshelfIxekizumab for treating active psoriatic arthritis after inadequate response to DMARDs.Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs.

Leave a Comment / Uncategorized / admin

Post Content

Uncategorized

New Releases from NCBI BookshelfDinutuximab beta for treating neuroblastoma.Dinutuximab beta for treating neuroblastoma.

Leave a Comment / Uncategorized / admin

Post Content

Uncategorized

New Releases from NCBI BookshelfPertuzumab: Therapeutic area: Early-stage breast cancer: Reimbursement Review [Internet].Pertuzumab: Therapeutic area: Early-stage breast cancer: Reimbursement Review [Internet].

Leave a Comment / Uncategorized / admin

HER2-positive breast cancer is a subtype of breast cancer characterized by overexpression of the HER2 protein, which is associated with

Uncategorized

New Releases from NCBI BookshelfComparative Effectiveness of Focused Ultrasound Therapy for Movement Disorders.Comparative Effectiveness of Focused Ultrasound Therapy for Movement Disorders.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfUsing Graphic Novels when Choosing Treatment for Alcohol Use Disorder [Internet].Using Graphic Novels when Choosing Treatment for Alcohol Use Disorder [Internet].

New Releases from NCBI BookshelfDeveloping and Testing a New Method for Comparing More Than Two Treatments Using Electronic Health Records [Internet].Developing and Testing a New Method for Comparing More Than Two Treatments Using Electronic Health Records [Internet].

New Releases from NCBI BookshelfLutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours.Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours.

New Releases from NCBI BookshelfIsatuximab (Sarclisa): Therapeutic area: Multiple myeloma: Reimbursement Review [Internet].Isatuximab (Sarclisa): Therapeutic area: Multiple myeloma: Reimbursement Review [Internet].

New Releases from NCBI BookshelfIxekizumab for treating active psoriatic arthritis after inadequate response to DMARDs.Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs.

New Releases from NCBI BookshelfDinutuximab beta for treating neuroblastoma.Dinutuximab beta for treating neuroblastoma.

New Releases from NCBI BookshelfPertuzumab: Therapeutic area: Early-stage breast cancer: Reimbursement Review [Internet].Pertuzumab: Therapeutic area: Early-stage breast cancer: Reimbursement Review [Internet].

New Releases from NCBI BookshelfComparative Effectiveness of Focused Ultrasound Therapy for Movement Disorders.Comparative Effectiveness of Focused Ultrasound Therapy for Movement Disorders.

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.